JPS5813551B2 - Sinquinapiride (4,3-D) Pyrimidinedione - Google Patents

Sinquinapiride (4,3-D) Pyrimidinedione

Info

Publication number
JPS5813551B2
JPS5813551B2 JP50031583A JP3158375A JPS5813551B2 JP S5813551 B2 JPS5813551 B2 JP S5813551B2 JP 50031583 A JP50031583 A JP 50031583A JP 3158375 A JP3158375 A JP 3158375A JP S5813551 B2 JPS5813551 B2 JP S5813551B2
Authority
JP
Japan
Prior art keywords
group
general formula
substituted
alkoxy group
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP50031583A
Other languages
Japanese (ja)
Other versions
JPS51108091A (en
Inventor
井出博之
宮田悟
中川晃
野田寛治
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Priority to JP50031583A priority Critical patent/JPS5813551B2/en
Publication of JPS51108091A publication Critical patent/JPS51108091A/en
Publication of JPS5813551B2 publication Critical patent/JPS5813551B2/en
Expired legal-status Critical Current

Links

Description

【発明の詳細な説明】 本発明は一般式(1) (式中、Rは(1)低級アルキル基、(2)ハロゲン原
子、低級シクロアルキル基、低級アルコキシ基又は置換
もしくは無置換のフエニル基で置換された低級アルキル
基、(3)アルケニル基又は(4)アルキニル基を意味
する)で表わされる新規なピリド〔4,3−d〕ピリミ
ジンー2 .4( IH,3H)一ジオン誘導体の製造
法に関するものである。
Detailed Description of the Invention The present invention is based on the general formula (1) (wherein R is (1) a lower alkyl group, (2) a halogen atom, a lower cycloalkyl group, a lower alkoxy group, or a substituted or unsubstituted phenyl group). A novel pyrido[4,3-d]pyrimidine-2. The present invention relates to a method for producing a 4(IH,3H) monodione derivative.

更に詳しくは一般式(II) (式中、Xは(1)低級アルコキシ基、(2)低級アル
キルアミノ基、(3)ハロゲン原子、低級シクロアルキ
ル基、低級アルコキシ基又は置換もしくは無置換のフエ
.ニル基で置換された低級アルキルアミノ基、(4)ア
ルケニル基又はアルキニル基で置換されたアミン基を意
味する)で表わされる化合物に一般式(IID (式中、Rは前記と同じ意味を有する)で表わされるイ
ソジアネート類を反応させ、前記一般式(I)で表わさ
れる化合物を製造する方法に関するものである。
More specifically, the general formula (II) (wherein, A lower alkylamino group substituted with a nyl group, (4) an alkenyl group or an amine group substituted with an alkynyl group) is added to a compound represented by the general formula (IID (wherein, R has the same meaning as above). The present invention relates to a method for producing a compound represented by the general formula (I) by reacting isocyanates represented by the formula (I).

前記一般式(I) , (II)及び(I[I)におけ
るX及びHに就いて更に詳細に説明すると,Xの低級ア
ルコキシ基はメトキシ、エトキシ等の低級アルコキシ基
を、R及びXの低級アルキル基はメチル、エチル、n一
プロビル、イソプロビル、n−ブチル、イソブチル等の
低級アルキル基を、置換低級アルキル基はハロゲン原子
、低級シクロアルキル基、アルコキシ基、アリール基等
で置換された低級アルキル基を、不飽和アルキル基はア
リル等のアルケニル基及びプロパルギル等のアルキニル
基を表わす。
To explain in more detail about X and H in the above general formulas (I), (II) and (I[I), the lower alkoxy group of X is a lower alkoxy group such as methoxy or ethoxy, and the lower alkoxy group of R and The alkyl group is a lower alkyl group such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, etc., and the substituted lower alkyl group is a lower alkyl group substituted with a halogen atom, lower cycloalkyl group, alkoxy group, aryl group, etc. The unsaturated alkyl group represents an alkenyl group such as allyl and an alkynyl group such as propargyl.

本発明の出発原料である一般式(II)で表わされる化
合物は4−(m−1リフルオロメチルアニリノ)ニコチ
ン酸及びその反応性誘導体に、相当するアルコール類及
びアミン類を反応させることによって収量よく得られる
The compound represented by the general formula (II), which is the starting material of the present invention, can be obtained by reacting 4-(m-1-lifluoromethylanilino)nicotinic acid and its reactive derivatives with the corresponding alcohols and amines. Good yield is obtained.

本発明を反応式で示すと次の通りである。The reaction formula of the present invention is as follows.

前記の反応式はテトラヒド口フラン、ジグリム、ジオキ
サン、ベンゼン、ジメチルホルムアミド等の不活性有機
溶媒中、ナトリウムアルコラート、,水素化ナトリウム
、水素化カリウム、ナトリウムアミド等の金属化合物の
存在下に、相当するインシアネートを反応させることに
よっておこなわれる。
The above reaction formula corresponds to the reaction in the presence of metal compounds such as sodium alcoholate, sodium hydride, potassium hydride, sodium amide, etc. in an inert organic solvent such as tetrahydrofuran, diglyme, dioxane, benzene, dimethylformamide, etc. This is done by reacting incyanate.

反応温度は特に限定されず室温でも進行するが、好まし
くは使用する溶媒の沸点か又は沸点近くで行なうのがよ
い。
The reaction temperature is not particularly limited and may proceed at room temperature, but it is preferably carried out at or near the boiling point of the solvent used.

反応生成物は減圧下に溶媒を留去し、残渣をメタノール
、エーテル等の有機溶媒で再結晶するか、又はカラムク
ロマト法により分離精製することによって純品を得るこ
とが出来る。
A pure product can be obtained from the reaction product by distilling off the solvent under reduced pressure and recrystallizing the residue from an organic solvent such as methanol or ether, or by separating and purifying it by column chromatography.

本発明で得られた化合物は文献未載の新規化合物で有り
、顕著な鎮痛作用、抗炎症作用及び中枢神経抑制作用等
の薬理作用を有し、医薬品として産業上有用な化合物で
ある。
The compound obtained in the present invention is a new compound that has not been described in any literature, and has pharmacological effects such as remarkable analgesic effect, anti-inflammatory effect, and central nervous system depressing effect, and is an industrially useful compound as a pharmaceutical.

以下に実施例を示し本発明を更に具体的に説明する。EXAMPLES The present invention will be explained in more detail with reference to Examples below.

実施例゛ 1 4−(m− ト’Jフルオロメチルアニリノ)ニコチン
酸メチルエステル3.0gをテトラヒド口フラン20m
lに溶解し、約′50%の水素化ナトリウム0.6gを
加え室温で15分間攪拌した。
Example 1 3.0 g of 4-(m-t'J fluoromethylanilino)nicotinic acid methyl ester was dissolved in 20 m of tetrahydrofuran.
0.6 g of about 50% sodium hydride was added, and the mixture was stirred at room temperature for 15 minutes.

次にアリルイソシアネート2.4gとテトラヒド口フラ
ン10WLlの溶液を冷却下に加え室温で1時間、次に
還流下3時間反応させた。
Next, a solution of 2.4 g of allyl isocyanate and 10 WL of tetrahydrofuran was added under cooling, and the mixture was reacted for 1 hour at room temperature and then for 3 hours under reflux.

反応終了後、減圧下に溶媒を留去し、残渣に水を加え析
出した結晶をエーテルより再結晶して、無色プリズム晶
の1−(m一トリフルオロメチルフエニル)−3−7’
lJルピリド(4.3−d)ピリミジン−2,4( I
H,3H)一ジオン2.5gを得た。
After the reaction, the solvent was distilled off under reduced pressure, water was added to the residue, and the precipitated crystals were recrystallized from ether to give colorless prism crystals of 1-(m-trifluoromethylphenyl)-3-7'.
lJ Lupirido (4.3-d) Pyrimidine-2,4 (I
2.5 g of H,3H) monodione were obtained.

この物質の融点及び元素分析値は次の通りであった。The melting point and elemental analysis values of this substance were as follows.

? 点 180〜181°C 元素分析値 CI7F■lF3N30 理論値C:58.79 H:3.49 N:1210実
測値C:58.67 H:3.42 N:1213実施
例 2 4 − ( +η一トリフルオロメチルアニリノ)ニコ
チン酸エチルアミド31gをジグリム20mlに溶解後
、約50%の水素化ナl− IJウム1.Ogを加え室
温で15分間攪拌した。
? Point 180-181°C Elemental analysis value CI7F■lF3N30 Theoretical value C: 58.79 H: 3.49 N: 1210 Actual value C: 58.67 H: 3.42 N: 1213 Example 2 4 - (+η- After dissolving 31 g of trifluoromethylanilino)nicotinic acid ethylamide in 20 ml of diglyme, approximately 50% sodium hydride was added. Og was added and the mixture was stirred at room temperature for 15 minutes.

次にエチルイソシアネート21gとジグリム10mlの
溶液を冷却下に加え室温で1時間攪拌後、還流下に2時
間反応させた。
Next, a solution of 21 g of ethyl isocyanate and 10 ml of diglyme was added under cooling, and after stirring at room temperature for 1 hour, the mixture was reacted under reflux for 2 hours.

反応終了後、減圧下に溶媒を留去し、残渣に水を加えエ
ーテルで抽出、脱水後濃縮すると、無色プリズム晶の1
−(m一トリフルオロメチルフエニル)−3−エチルピ
リド(4.3−d)ピリミジン−2.4(IH,3H)
一ジオン2.2gを得た。
After the reaction, the solvent was distilled off under reduced pressure, water was added to the residue, extracted with ether, dehydrated, and concentrated to obtain colorless prism crystals.
-(m-trifluoromethylphenyl)-3-ethylpyrido(4.3-d)pyrimidine-2.4(IH,3H)
2.2 g of dione was obtained.

この物質の融点及び元素分析値は次の通りであった。The melting point and elemental analysis values of this substance were as follows.

融 点 144〜145°C 元素分析値 C16Hl2F3N30。Melting point 144-145°C Elemental analysis value C16Hl2F3N30.

理論値C:57.31 H:3.61 N:12.53
実測値C:57.23 H:3.57 N:1248実
施例 3 4−(m一トリフルオロメチルアニリノ)ニコチン酸一
〇一プチルアミド3.4gをテトラヒド口フラン20m
lに溶解し、ナトリウムアミド0.8gを加え室温で1
5分間攪拌した。
Theoretical value C: 57.31 H: 3.61 N: 12.53
Actual value C: 57.23 H: 3.57 N: 1248 Example 3 3.4 g of 4-(m-trifluoromethylanilino)nicotinic acid 101 butylamide was added to 20 m of tetrahydrofuran.
1, add 0.8 g of sodium amide and stir at room temperature.
Stir for 5 minutes.

次にメチルイソシアネート1.7gとテトラヒド口フラ
ン10mlの溶液を冷却下に加え室温で30分間攪拌後
、還流下に3時間反応させた。
Next, a solution of 1.7 g of methyl isocyanate and 10 ml of tetrahydrofuran was added under cooling, and after stirring at room temperature for 30 minutes, the mixture was reacted under reflux for 3 hours.

反応終了後、減圧下に溶媒を留去し、残渣に水を加え析
出した結晶をメタノールとエーテルの混合溶媒より再結
晶して、無色プリズム晶の1−(m−トリフルオロメチ
ルフエニル)−3−メチルピリド[4,3−d)ピリミ
ジン−2 .4( IH,3H)一ジオン2.1gを得
た。
After the reaction, the solvent was distilled off under reduced pressure, water was added to the residue, and the precipitated crystals were recrystallized from a mixed solvent of methanol and ether to obtain colorless prismatic crystals of 1-(m-trifluoromethylphenyl)- 3-Methylpyrido[4,3-d)pyrimidine-2. 2.1 g of 4(IH,3H)-dione was obtained.

?の物質の融点及び元素分析値は次の通りであった。? The melting point and elemental analysis values of the substance were as follows.

融 点 178〜180°C 元素分析値 C1,H1oF3N30 理論値C:56.08 H:3.14 N:13.08
実測値C:56.01 H:318 N:13.11実
施例 4〜11 実施例1〜3の方法に準じて次表に示す化合物を好収量
で得た。
Melting point 178-180°C Elemental analysis value C1, H1oF3N30 Theoretical value C: 56.08 H: 3.14 N: 13.08
Actual value C: 56.01 H: 318 N: 13.11 Examples 4 to 11 According to the method of Examples 1 to 3, the compounds shown in the following table were obtained in good yields.

Claims (1)

【特許請求の範囲】 1 一般式 (式中、Xは(1)低級アルコキシ基、(2)低級アル
キルアミノ基、(3)ハロゲン原子、低級シクロアルキ
ル基、低級アルコキシ基又は置換もしくは無置換のフエ
ニル基で置換された低級アルキルアミノ基、(4)アル
ケニル基又はアルキニル基で置換されたアミ7基を意味
する)で表わされる化合物に一般式 (式中、Rは(1)低級アルキル基、(2)ハロゲン原
子、低級シクロアルキル基、低級アルコキシ基又は置換
もしくは無置換アルコキシ基で置換された低級アルキル
基、(3)アルケニル基又は(4)アルキニル基を意味
する)で表わされる化合物を反応させるこちを特徴とす
る一般式 (式中、Rは前記と同じ意味を有する)で表わされる新
規なピリド(4.3−d)ピリミジンジオン誘導体の製
造法。
[Claims] 1 General formula (wherein X is (1) a lower alkoxy group, (2) a lower alkylamino group, (3) a halogen atom, a lower cycloalkyl group, a lower alkoxy group, or a substituted or unsubstituted A compound represented by the general formula (wherein R is (1) a lower alkyl group, (2) A compound represented by a halogen atom, a lower cycloalkyl group, a lower alkoxy group, a lower alkyl group substituted with a substituted or unsubstituted alkoxy group, (3) an alkenyl group, or (4) an alkynyl group) is reacted. A method for producing a novel pyrido(4.3-d)pyrimidinedione derivative represented by the general formula (wherein R has the same meaning as above) characterized by the following:
JP50031583A 1975-03-15 1975-03-15 Sinquinapiride (4,3-D) Pyrimidinedione Expired JPS5813551B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP50031583A JPS5813551B2 (en) 1975-03-15 1975-03-15 Sinquinapiride (4,3-D) Pyrimidinedione

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50031583A JPS5813551B2 (en) 1975-03-15 1975-03-15 Sinquinapiride (4,3-D) Pyrimidinedione

Publications (2)

Publication Number Publication Date
JPS51108091A JPS51108091A (en) 1976-09-25
JPS5813551B2 true JPS5813551B2 (en) 1983-03-14

Family

ID=12335197

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50031583A Expired JPS5813551B2 (en) 1975-03-15 1975-03-15 Sinquinapiride (4,3-D) Pyrimidinedione

Country Status (1)

Country Link
JP (1) JPS5813551B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808618A (en) * 1986-04-16 1989-02-28 Nippon Zoki Pharmaceutical Co., Ltd. Substituted 1,3-dialkylpyrido[4,3-d]pyrimidine-2,4-diones
PH23853A (en) * 1986-08-21 1989-11-23 Pfizer Pyridopyrimidinediones

Also Published As

Publication number Publication date
JPS51108091A (en) 1976-09-25

Similar Documents

Publication Publication Date Title
US3226424A (en) Process for preparing 2-lower alkoxy-1,1-dicyanoethylene and 2-amino-1,1-dicyanoethylene
JPS5813551B2 (en) Sinquinapiride (4,3-D) Pyrimidinedione
US3056786A (en) C-substituted piperazine derivatives and method
JPS5920676B2 (en) Method for producing a novel pyrimido[4,5-d]pyrimidine derivative
JPS5920677B2 (en) Method for producing a novel pyrimido[4,5-d]pyrimidinedione derivative
JPS5813550B2 (en) Sinquinapiride (4,3-D) Pyrimidinedione
JPS5813553B2 (en) Sinquinapiride (4,3-D) Pyrimidinedione
JPH061776A (en) Production of substituted pyrazinecarbonitrile
JPS5813552B2 (en) Sinquinapiride (4,3-D) Pyrimidinedione
JPH083143A (en) Production of 6-aralkyl substituted pyrimidine derivative
JPS5829792B2 (en) Sinquinapiride (4,3-D) Pyrimidinedione
JPS5813547B2 (en) Cinquinapiride (2,3-D) Pyrimidinedione
JP3005080B2 (en) Method for producing cyclopenta [d] pyrimidin-4-ones
JPS58429B2 (en) Synquina 2-oxo-1,2,3,4-tetrahydropyride (2,3-D) Pyrimidine
JPS582950B2 (en) Sinquinapyridopyrimidinedione
JP2604589B2 (en) Method for producing imidazolidine derivative
JPS582947B2 (en) Sinquinapyridopyrimidinedione
US2761862A (en) Process for the manufacture of xanthine derivatives
JPH0285237A (en) Production of methyl 3- aminocrotanate
JPS5920674B2 (en) Pyrido (2,3-D) Pyrimidine
KR800000431B1 (en) Preparing process for 3-isoxazolyl urea derivatives
JPS584033B2 (en) Method for producing a novel pyrido[2,3-d]pyrimidine-2-thione derivative
JPS58432B2 (en) Cinquinapiride -1,4- Diazepine
JPS5920675B2 (en) Method for producing a novel pyrimido[4,5-d]pyrimidine derivative
JPS5833232B2 (en) Sinquinapyridopyrimidinedione